Eurizon Capital SGR S.p.A. Takes $23.09 Million Position in GE HealthCare Technologies Inc. $GEHC

Eurizon Capital SGR S.p.A. acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, Holdings Channel reports. The firm acquired 281,537 shares of the company’s stock, valued at approximately $23,093,000.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after buying an additional 267,058 shares in the last quarter. Dodge & Cox lifted its position in shares of GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after buying an additional 3,949,361 shares in the last quarter. Capital Research Global Investors lifted its position in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after buying an additional 4,998,154 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock worth $989,673,000 after buying an additional 37,159 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 17.1% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after buying an additional 1,232,828 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on GEHC. Oppenheimer reiterated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Argus decreased their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Mizuho decreased their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Evercore set a $80.00 target price on GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a research report on Wednesday, April 29th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $80.21.

Insider Activity at GE HealthCare Technologies

In related news, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The shares were bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. The trade was a 3.93% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the purchase, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 21,847 shares of company stock valued at $1,361,355 over the last ninety days. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Down 0.8%

Shares of NASDAQ GEHC opened at $62.34 on Friday. The business’s 50 day moving average is $67.68 and its two-hundred day moving average is $75.86. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The stock has a market capitalization of $28.36 billion, a P/E ratio of 14.91, a PEG ratio of 1.40 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the previous year, the firm earned $1.01 earnings per share. The company’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.